1-4 of 4
Greg Evans
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

New Approach for Finding Novel Antisickling Agents at the NIH NHLBI Sickle Cell Disease Reference Laboratory.

Toshio Asakura, MD, PhD, Jisheng Yang, Qiukan Chen, MD, Greg Evans, PhD, Osheiza Abdulmalik, DVM
Journal: Blood
Blood (2006) 108 (11): 1219.
https://doi.org/10.1182/blood.V108.11.1219.1219
Published: 2006
Journal Articles

Various Drugs with or without an Antisickling Effect in the In Vitro Tests Showed a Strong Antisickling Effect in the In Vivo Studies in Transgenic Sickle Mice.

Toshio Asakura, MD, PhD, Osheiza Abdulmalik, DVM, Efe Iyamu, PhD, Qiukan Chen, MD, Jisheng Yang, Donald J. Abraham, PhD, Martin K. Safo, PhD, Carlo Brugnara, MD, Greg Evans, PhD
Journal: Blood
Blood (2005) 106 (11): 3190.
https://doi.org/10.1182/blood.V106.11.3190.3190
Published: 2005
Journal Articles

Finding of 8 New Therapeutic Agents by the Use of New High-Throughput Drug Screening Methods Established by the Nhlbi Sicke Cell Disease Reference Laboratory.

Toshio Asakura, MD, PhD, Osheiza Abdulmalik, DVM, Efe Iyamu, PhD, Qiukan Chen, MD, Jisheng Yang, Carlo Brugnara, MD, Greg Evans, PhD
Journal: Blood
Blood (2004) 104 (11): 3751.
https://doi.org/10.1182/blood.V104.11.3751.3751
Published: 2004
Journal Articles

Treatment with NS3623, a novel Cl-conductance blocker, ameliorates erythrocyte dehydration in transgenic SAD mice: a possible new therapeutic approach for sickle cell disease

Poul Bennekou, Lucia de Franceschi, Ove Pedersen, Lurong Lian, Toshio Asakura, Greg Evans, Carlo Brugnara, Palle Christophersen
Journal: Blood
Blood (2001) 97 (5): 1451–1457.
https://doi.org/10.1182/blood.V97.5.1451
Published: 2001